1 line
3.6 KiB
JSON
1 line
3.6 KiB
JSON
{"abdominal discomfort": 3.97, "abdominal distension": 7.22, "abdominal pain": 3.55, "abdominal pain upper": 3.8, "accidental overdose": 2.88, "accidental underdose": 30.01, "amylase increased": 12.37, "appetite disorder": 2.35, "back disorder": 2.01, "biliary colic": 4.95, "blindness": 2.49, "blood glucose abnormal": 12.23, "blood glucose decreased": 8.22, "blood glucose fluctuation": 3.04, "blood glucose increased": 10.59, "blood triglycerides increased": 6.09, "brain neoplasm": 2.18, "breath odour": 11.15, "cholecystitis": 3.35, "cholecystitis acute": 3.56, "cholelithiasis": 6.03, "constipation": 5.66, "decreased appetite": 4.71, "dehydration": 5.19, "dementia": 2.68, "dementia alzheimer's type": 3.19, "diabetes mellitus inadequate control": 5.96, "diabetic complication": 6.77, "diabetic ketoacidosis": 4.5, "diabetic neuropathy": 4.34, "diabetic retinopathy": 9.37, "diarrhoea": 3.91, "dyspepsia": 6.28, "eating disorder": 2.59, "eructation": 60.91, "extra dose administered": 7.72, "faeces hard": 6.08, "feeding disorder": 10.88, "flatulence": 12.06, "fluid intake reduced": 4.56, "food craving": 8.59, "gallbladder disorder": 2.34, "gastroenteritis viral": 3.3, "gastrointestinal disorder": 6.0, "gastrointestinal pain": 2.39, "gastrointestinal sounds abnormal": 4.57, "gastrooesophageal reflux disease": 5.29, "glomerular filtration rate decreased": 5.04, "glycosylated haemoglobin abnormal": 17.29, "glycosylated haemoglobin decreased": 19.58, "glycosylated haemoglobin increased": 33.41, "hepatic steatosis": 2.01, "hiccups": 6.78, "hunger": 7.45, "hyperlipasaemia": 16.87, "hypoglycaemia": 3.18, "hypophagia": 4.23, "ileus": 3.05, "illness": 3.54, "impaired gastric emptying": 22.78, "inappropriate schedule of product administration": 2.57, "incorrect dose administered": 3.7, "increased appetite": 2.92, "injection site bruising": 12.92, "injection site discomfort": 4.79, "injection site erythema": 4.55, "injection site haematoma": 2.81, "injection site haemorrhage": 17.71, "injection site hypersensitivity": 30.91, "injection site induration": 3.19, "injection site injury": 21.63, "injection site irritation": 12.17, "injection site mass": 14.86, "injection site nodule": 5.19, "injection site oedema": 4.42, "injection site pain": 2.57, "injection site plaque": 22.67, "injection site pruritus": 12.94, "injection site rash": 14.38, "injection site reaction": 2.85, "injection site urticaria": 8.69, "injection site vesicles": 8.02, "injury associated with device": 7.71, "intestinal obstruction": 4.29, "ketoacidosis": 4.78, "lipase increased": 30.31, "macular degeneration": 2.48, "medullary thyroid cancer": 49.31, "nausea": 3.72, "nephrolithiasis": 2.04, "obesity": 2.01, "obstructive pancreatitis": 14.24, "pancreatic carcinoma": 3.82, "pancreatic carcinoma metastatic": 9.13, "pancreatic cyst": 9.04, "pancreatic disorder": 14.74, "pancreatic enzymes increased": 6.56, "pancreatic failure": 13.08, "pancreatic mass": 12.77, "pancreatitis": 31.53, "pancreatitis acute": 13.9, "pancreatitis chronic": 6.58, "pancreatitis necrotising": 7.63, "papillary thyroid cancer": 6.74, "product administered at inappropriate site": 7.06, "product dose omission issue": 3.66, "product storage error": 3.38, "regurgitation": 3.88, "renal disorder": 2.65, "retching": 2.11, "retinal detachment": 2.18, "retinopathy": 4.85, "sleep disorder due to a general medical condition": 3.29, "sleep disorder due to general medical condition, insomnia type": 7.11, "small intestinal obstruction": 5.65, "thyroid cancer": 3.84, "thyroid mass": 5.8, "thyroid neoplasm": 25.12, "vomiting": 5.17, "vomiting projectile": 8.23, "weight decreased": 7.36, "weight increased": 2.29} |